皮塔瓦斯塔丁降低了巨细胞B型清理受体CD36的表达
Jihong Han1, Xiaoye Zhou, Toru Yokoyama
1Center of Vascular Biology and Department of Pathology, Weill Medical College of Cornell University, 1300 York Ave, New York, NY 10021, USA.
Circulation
|February 19, 2004
概括
皮塔瓦斯塔丁通过抑制CD36表达来减少巨细胞对氧化LDL的吸收. 这表明皮塔瓦斯塔丁可以防止动脉样硬化中的泡细胞形成.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 药理学 药理学 是一个学科.
背景情况:
- 皮塔瓦斯塔丁是一种新型的HMG-CoA减少酶抑制剂,用于降低胆固醇.
- 在巨细胞中氧化的LDL积累是动脉样硬化中泡细胞形成的关键.
- CD36拾尸体受体在氧化LDL吸收中发挥着关键作用.
研究的目的:
- 为了研究皮塔瓦斯塔丁对巨细胞中CD36表达的作用.
- 确定皮塔瓦斯塔丁影响CD36表达的机制.
- 探索皮塔瓦斯塔丁对氧化LDL吸收和泡细胞形成的影响.
主要方法:
- 用皮塔瓦斯塔丁对J774细胞和小鼠巨细胞进行剂量依赖的治疗.
- 在各种细胞类型中分析CD36mRNA和蛋白质表达.
- 调查皮塔瓦斯塔丁对增殖器激活受体- (PPARgamma) 和MAPK信号通路的影响.
主要成果:
- 皮塔瓦斯塔丁显著降低了巨细胞中的CD36mRNA和蛋白质表达.
- 皮塔瓦斯塔丁降低了氧化LDL的结合和巨细胞的吸收.
- 皮塔瓦斯塔丁降低了PPARgamma表达和调节了PPARgamma酸化.
结论:
- 皮塔瓦斯塔丁抑制了巨细胞的CD36表达,从而阻止了氧化LDL的吸收.
- 该机制涉及PPARgamma依赖的CD36.6的转录下调.
- 皮塔瓦斯塔丁在动脉样硬化中显示出调节CD36介导泡细胞形成的潜力.
相关概念视频
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K


